Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Difference in Membrane Repair Capacity Between Cancer Cell Lines and a Normal Cell Line

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Diffusion-weighted MRI for verification of electroporation-based treatments

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  2. Calcium electroporation for recurrent head and neck cancer: A clinical phase I study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Electrochemotherapy for Breast Cancer-Results From the INSPECT Database

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Electroporation-based treatments and other therapies that permeabilize the plasma membrane have been shown to be more devastating to malignant cells than to normal cells. In this study, we asked if a difference in repair capacity could explain this observed difference in sensitivity. Membrane repair was investigated by disrupting the plasma membrane using laser followed by monitoring fluorescent dye entry over time in seven cancer cell lines, an immortalized cell line, and a normal primary cell line. The kinetics of repair in living cells can be directly recorded using this technique, providing a sensitive index of repair capacity. The normal primary cell line of all tested cell lines exhibited the slowest rate of dye entry after laser disruption and lowest level of dye uptake. Significantly, more rapid dye uptake and a higher total level of dye uptake occurred in six of the seven tested cancer cell lines (p < 0.05) as well as the immortalized cell line (p < 0.001). This difference in sensitivity was also observed when a viability assay was performed one day after plasma membrane permeabilization by electroporation. Viability in the primary normal cell line (98 % viable cells) was higher than in the three tested cancer cell lines (81–88 % viable cells). These data suggest more effective membrane repair in normal, primary cells and supplement previous explanations why electroporation-based therapies and other therapies permeabilizing the plasma membrane are more effective on malignant cells compared to normal cells in cancer treatment.
OriginalsprogEngelsk
TidsskriftJournal of Membrane Biology
Udgave nummerdoi: 10.1007
Sider (fra-til)569-576
ISSN0022-2631
StatusUdgivet - 2016

ID: 49778191